Amgen To Present At The 34th Annual J.P. Morgan Healthcare Conference
Get Alerts AMGN Hot Sheet
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 3.3%
EPS Growth %: -2.3%
Join SI Premium – FREE
THOUSAND OAKS, Calif., Jan. 7, 2016 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the 34th Annual J.P. Morgan Healthcare Conference at 8 a.m. PT on Tuesday, Jan. 12, 2016, at the Westin St. Francis in San Francisco. Robert A. Bradway, chairman and chief executive officer at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.
About AmgenAmgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.
CONTACT: Amgen, Thousand OaksKristen Davis, 805-447-3008 (media)Kristen Neese, 805-313-8267 (media)Arvind Sood, 805-447-1060 (investors)
Logo - http://photos.prnewswire.com/prnh/20081015/AMGENLOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-34th-annual-jp-morgan-healthcare-conference-300201244.html
SOURCE Amgen
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UAB Partnerystės projektai keturi 2023 audited annual report
- Phoenix Motor Strengthens Capital Structure by Negotiating Key Waiver with Note Holder
- Trakx launches a new product: Trakx USDc Earn CTI powered by OpenTrade
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
JPMorgan, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!